Paradeep Phosphates (PARADEEP) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
8 Jul, 2026Executive summary
The MCFL merger was completed and consolidated from April 2024, increasing production capacity by 23% to 3.7 million MT and expanding the national market presence, with financials restated accordingly.
Q2 FY26 saw 49% YoY growth in total income to ₹6,872 crore, with net profit up 33.9% YoY to ₹341.9 crore; H1 FY26 net profit rose 134.7% YoY to ₹658.7 crore, and EBITDA up 69.3% YoY to ₹13,131 million.
Announced a strategic INR 3,600 crore investment program for granulation and acid capacities, targeting 5 million tons total capacity and 100% backward integration within 2.5 years.
Expanded distribution network now reaches over 10 million farmers across 18 states, supported by 75,000 retailers and 6,000 dealers.
Appointed Rahul Dravid as brand ambassador and onboarded new directors to strengthen market presence and governance.
Financial highlights
Q2 revenue from operations grew 49% YoY to INR 6,872 crore; EBITDA margin at 10.1%, net profit margin at 4.9%; H1 EBITDA margin at 11.5%, net profit margin at 5.8%.
H1 revenue rose 46%, EBITDA 69%, and PAT 135% YoY, reflecting strong volume growth and improved product mix.
Basic EPS for H1 FY26 at ₹6.35, up 134.3% YoY.
Cash conversion cycle improved by 30 days to 58 days; net debt to equity at 0.66.
Outlook and guidance
Optimistic demand outlook driven by favorable rabi season, government focus on soil health, and shift to specialized nutrients.
Strategic priorities include scaling efficiency, deepening backward integration, accelerating product innovation, and embedding sustainability.
Full capacity from new investments expected by end of FY28, with peak revenues in FY29; targeting 5.0 MMTPA sales.
EBITDA per ton expected to rise by INR 1,000 post full backward integration, reaching INR 5,500–6,500 per ton.
Latest events from Paradeep Phosphates
- Revenue up 36% YoY, EBITDA up 25%, with strong DAP sales and MCFL merger boosting growth.PARADEEP
Q1 26/2731 Jul 2026 - Strong growth in revenue, profit, and volumes, boosted by MCFL merger and expansion projects.PARADEEP
Q3 25/268 Jul 2026 - Q1 FY26 revenue up 58% YoY, EBITDA nearly doubled, and MCFL merger nears completion.PARADEEP
Q1 25/268 Jul 2026 - Strong revenue and profit growth, major merger, and expanded NPK and value-added product capacity.PARADEEP
Q4 25/2619 May 2026 - Profitability improved despite lower Q1 volumes; new launches and merger progress support outlook.PARADEEP
Q1 24/259 Feb 2026 - Q3 FY25 delivered strong revenue and profit growth, with expansion and merger plans advancing.PARADEEP
Q3 24/2519 Dec 2025 - Record profit and sales growth, strong cash flow, and capacity expansion ahead.PARADEEP
Q4 24/2519 Dec 2025 - Q2 FY25 profit soared 155% YoY, with major phosphoric acid expansion approved.PARADEEP
Q2 24/2519 Dec 2025